NEW CHEMERIN R AGONIST
PROBLEM TO BE SOLVED: To provide a new Chem R23 agonist and use thereof. SOLUTION: A peptide represented by the sequence: tyr-Phe-Leu-Pro-X1-Gln-Phe-X2-X3-Ser [wherein tyr is D-Tyr; X1 is D-Ala or D-Ser; X2 is Ala or D-Ala; and X3 is D-Phe or Tic] is a biologically stable Chem R23 agonist. COPYRIGHT...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
14.10.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PROBLEM TO BE SOLVED: To provide a new Chem R23 agonist and use thereof. SOLUTION: A peptide represented by the sequence: tyr-Phe-Leu-Pro-X1-Gln-Phe-X2-X3-Ser [wherein tyr is D-Tyr; X1 is D-Ala or D-Ser; X2 is Ala or D-Ala; and X3 is D-Phe or Tic] is a biologically stable Chem R23 agonist. COPYRIGHT: (C)2011,JPO&INPIT |
---|---|
AbstractList | PROBLEM TO BE SOLVED: To provide a new Chem R23 agonist and use thereof. SOLUTION: A peptide represented by the sequence: tyr-Phe-Leu-Pro-X1-Gln-Phe-X2-X3-Ser [wherein tyr is D-Tyr; X1 is D-Ala or D-Ser; X2 is Ala or D-Ala; and X3 is D-Phe or Tic] is a biologically stable Chem R23 agonist. COPYRIGHT: (C)2011,JPO&INPIT |
Author | YOSHIMOTO RYO TOKITA SHIGERU MIYAMOTO YASUHISA SHIMAMURA KEN MATSUDA MASAO |
Author_xml | – fullname: MATSUDA MASAO – fullname: TOKITA SHIGERU – fullname: MIYAMOTO YASUHISA – fullname: SHIMAMURA KEN – fullname: YOSHIMOTO RYO |
BookMark | eNrjYmDJy89L5WQQ83MNV3D2cPV1DfL0UwhScHT39_MMDuFhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhgZGRpYGlsaOxkQpAgCs2SEj |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | JP2010229093A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2010229093A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 11:46:03 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2010229093A3 |
Notes | Application Number: JP20090079044 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101014&DB=EPODOC&CC=JP&NR=2010229093A |
ParticipantIDs | epo_espacenet_JP2010229093A |
PublicationCentury | 2000 |
PublicationDate | 20101014 |
PublicationDateYYYYMMDD | 2010-10-14 |
PublicationDate_xml | – month: 10 year: 2010 text: 20101014 day: 14 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | BANYU PHARMACEUT CO LTD |
RelatedCompanies_xml | – name: BANYU PHARMACEUT CO LTD |
Score | 2.7913048 |
Snippet | PROBLEM TO BE SOLVED: To provide a new Chem R23 agonist and use thereof. SOLUTION: A peptide represented by the sequence: tyr-Phe-Leu-Pro-X1-Gln-Phe-X2-X3-Ser... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | NEW CHEMERIN R AGONIST |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101014&DB=EPODOC&locale=&CC=JP&NR=2010229093A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTExs7AwMzbRTTZKAnZQkg1NdBMTgYVhkkmyeYplUkqyCfjmOV8_M49QE68I0wgmhmzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dG4KvnlVzcbJ1DfB38XdWc3a29QpQ8wsCy4GONrc0dmRmYAW1o0EH7buGOYG2pRQg1yluggxsAUDj8kqEGJhS84QZOJ1hV68JM3D4Qme8gUxo5isWYRDzcw1XAB1hADoGSiFIwdHd388zOESUQcnNNcTZQxdoQTzcO_FeAUiOMRZjYAH281MlGBRSTFKSU4EBZJpongrsZpkkAfu55mZJwPZOWmoysFkpySCNxyApvLLSDFzgaW8QMpFhYCkpKk2VBdamJUly4FAAACRLdQw |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTExs7AwMzbRTTZKAnZQkg1NdBMTgYVhkkmyeYplUkqyCfjmOV8_M49QE68I0wgmhmzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dG4KvnlVzcbJ1DfB38XdWc3a29QpQ8wsCy4GONrc0dmRmYDUH9glBB-27hjmBtqUUINcpboIMbAFA4_JKhBiYUvOEGTidYVevCTNw-EJnvIFMaOYrFmEQ83MNVwAdYQA6BkohSMHR3d_PMzhElEHJzTXE2UMXaEE83DvxXgFIjjEWY2AB9vNTJRgUUkxSklOBAWSaaJ4K7GaZJAH7ueZmScD2TlpqMrBZKckgjccgKbyy8gycHiG-PvE-nn7e0gxc4ClwEDKRYWApKSpNlQXWrCVJcuAQAQDDb3f3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NEW+CHEMERIN+R+AGONIST&rft.inventor=MATSUDA+MASAO&rft.inventor=TOKITA+SHIGERU&rft.inventor=MIYAMOTO+YASUHISA&rft.inventor=SHIMAMURA+KEN&rft.inventor=YOSHIMOTO+RYO&rft.date=2010-10-14&rft.externalDBID=A&rft.externalDocID=JP2010229093A |